US firm McDermott Will & Emery has hired a new regulatory compliance partner in Shanghai in order to strengthen its white-collar and securities defense practice.
Michelle Gon joins the firm from Baker & McKenzie and will be based at the premises of McDermott’s strategic ally, MWE China Law Offices.
“In recent years, multinational companies and businesses have faced heightened regulatory scrutiny in China,” says McDermott Will & Emery’s co-chair, Jeffrey Stone. “What began as an anti-corruption drive against companies in the pharmaceutical and medical device industries has now expanded into a number of areas, including anti-monopoly practices, food safety and environmental protection.”
Gon is particularly focused on anti-corruption, anti-competition, anti-monopoly and anti-fraud matters. She primarily covers China corporate, investment, distribution, regulatory and compliance work from the anti-bribery perspective, including the Foreign Corrupt Practices Act (FCPA), anti-unfair competition, anti-monopoly law and anti-fraud angles.
McDermott Will & Emery has a strategic alliance with PRC-licensed firm MWE China Law Offices that enables its clients access to both US and Chinese law. MWE China’s lawyers are allowed to retain their Chinese law licenses and communicate with Chinese government agencies on legal issues, collect evidence, and represent clients in Chinese courts and before Chinese regulatory bodies.